Hong Kong · Delayed Price · Currency is HKD HighTide Therapeutics Statistics
Total Valuation
HKG:2511 has a market cap or net worth of HKD 1.67 billion. The enterprise value is 1.31 billion.
| Market Cap | 1.67B |
| Enterprise Value | 1.31B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2511 has 571.33 million shares outstanding. The number of shares has increased by 6.25% in one year.
| Current Share Class | 571.33M |
| Shares Outstanding | 571.33M |
| Shares Change (YoY) | +6.25% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 2.75% |
| Owned by Institutions (%) | 4.86% |
| Float | 285.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.11 |
| P/TBV Ratio | 4.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.82 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.35.
| Current Ratio | 5.41 |
| Quick Ratio | 5.12 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -94.57 |
Financial Efficiency
Return on equity (ROE) is -58.85% and return on invested capital (ROIC) is -28.13%.
| Return on Equity (ROE) | -58.85% |
| Return on Assets (ROA) | -25.15% |
| Return on Invested Capital (ROIC) | -28.13% |
| Return on Capital Employed (ROCE) | -49.35% |
| Weighted Average Cost of Capital (WACC) | 5.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.78M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HKG:2511 has paid 243,705 in taxes.
| Income Tax | 243,705 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.77% in the last 52 weeks. The beta is 0.29, so HKG:2511's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +69.77% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 3.15 |
| Relative Strength Index (RSI) | 51.00 |
| Average Volume (20 Days) | 1,505,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -248.79M |
| Pretax Income | -258.04M |
| Net Income | -272.60M |
| EBITDA | -247.67M |
| EBIT | -248.79M |
| Earnings Per Share (EPS) | -0.57 |
Balance Sheet
The company has 559.44 million in cash and 141.18 million in debt, with a net cash position of 418.26 million or 0.73 per share.
| Cash & Cash Equivalents | 559.44M |
| Total Debt | 141.18M |
| Net Cash | 418.26M |
| Net Cash Per Share | 0.73 |
| Equity (Book Value) | 405.80M |
| Book Value Per Share | 0.67 |
| Working Capital | 482.85M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.14M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:2511 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.25% |
| Shareholder Yield | -6.25% |
| Earnings Yield | -16.34% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |